The current study’s contribution regarding the significance of FAGs and PHKG2 in regulating NSCLC’s radiation sensitivity and resistance provides a promising outlook for developing effective radiotherapy strategies. This evidence concerns the gene PHKG2 and non-small cell lung carcinoma.